BLEOPRIM 15 mg polvere per soluzione iniettabile

DRUG3 trials

Sponsors

Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico, IRCCS Istituto Nazionale Tumori Fondazione Pascale

Conditions

CARCINOMA OF THE ORAL CAVITY AND OROPHARYNXLocally Advanced Pancreatic Cancerrelapsing vulvar carcinoma already subjected to multiple treatments

Phase 2

Electrochemotherapy with Carboplatinum plus Bleomycin versus Bleomycin alone in vulvar cancer: the ElechtraPlatinum Study. A Randomized Controlled Trial

Not yet recruitingCTIS2024-518370-14-00

Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientificorelapsing vulvar carcinoma already subjected to multiple treatments

Target: 92Updated: 2024-11-27

Prospective phase IIb study to evaluate the efficacy of laparoscopic electrochemotherapy in the treatment of locally advanced pancreatic cancer - ECT-LAPC Laparoscopic

Not yet recruitingCTIS2024-519067-17-00

IRCCS Istituto Nazionale Tumori Fondazione PascaleLocally Advanced Pancreatic Cancer

Target: 90Updated: 2024-12-02

Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlled trial (ECT-HN)

CompletedCTIS2025-520735-16-00

IRCCS Istituto Nazionale Tumori Fondazione PascaleCARCINOMA OF THE ORAL CAVITY AND OROPHARYNX

End: 2025-09-02Target: 96Updated: 2025-01-31